Genentech has announced that it has submitted a supplemental Biologics License Application

Source: Inpharma, Volume 1, Number 1663, 2008-11-08 , pp. 23-23(1)

Publisher: Adis International

Keywords: Bevacizumab, therapeutic use; Development-status; Glioblastoma, treatment

Document Type: Short communication

Publication date: 2008-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers